Detailed answers about SUNDI PHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was SUNDI PHARMA LIMITED founded?
SUNDI PHARMA LIMITED was officially incorporated on 19 March 2008 and is registered under company number 06538776. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SUNDI PHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SUNDI PHARMA LIMITED?
SUNDI PHARMA LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SUNDI PHARMA LIMITED do?
SUNDI PHARMA LIMITED operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is SUNDI PHARMA LIMITED's registered address?
The registered office address of SUNDI PHARMA LIMITED is UNIT 3 CHILTERN COURT, ASHERIDGE ROAD, CHESHAM, BUCKINGHAMSHIRE, ENGLAND, HP5 2PX. This is the official address filed with Companies House for legal and statutory correspondence.
Is SUNDI PHARMA LIMITED financially stable?
The most recent accounts for SUNDI PHARMA LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.
Does SUNDI PHARMA LIMITED have any charges or mortgages?
SUNDI PHARMA LIMITED has 3 registered charges, of which 3 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.